Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
10.73
-0.12 (-1.06%)
At close: Dec 4, 2025, 4:00 PM EST
10.70
-0.03 (-0.23%)
After-hours: Dec 4, 2025, 6:58 PM EST
Viatris Revenue
Viatris had revenue of $3.76B in the quarter ending September 30, 2025, with 0.23% growth. This brings the company's revenue in the last twelve months to $14.12B, down -6.14% year-over-year. In the year 2024, Viatris had annual revenue of $14.74B, down -4.46%.
Revenue (ttm)
$14.12B
Revenue Growth
-6.14%
P/S Ratio
0.90
Revenue / Employee
$441,388
Employees
32,000
Market Cap
12.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14.74B | -687.60M | -4.46% |
| Dec 31, 2023 | 15.43B | -835.80M | -5.14% |
| Dec 31, 2022 | 16.26B | -1.62B | -9.08% |
| Dec 31, 2021 | 17.89B | 5.94B | 49.73% |
| Dec 31, 2020 | 11.95B | 445.50M | 3.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
VTRS News
- 1 day ago - Viatris Inc. (VTRS) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha
- 2 days ago - Viatris Inc. (VTRS) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript - Seeking Alpha
- 3 days ago - Mapi Pharma is Seeking New Partnerships for Long-Acting Depot Drugs of Peptides for Self Administration - GlobeNewsWire
- 3 days ago - Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
- 10 days ago - Viatris to Participate in Upcoming Investor Conferences - PRNewsWire
- 16 days ago - Viatris Inc. (VTRS) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 21 days ago - Viatris Recognized as One of the Fortune World's Best Workplaces™ in 2025 - PRNewsWire
- 23 days ago - Viatris Inc. (VTRS) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha